Related Announcements

NOT-CA-21-101 - Notice of Special Interest (NOSI): Advancing the development of tumor site-activated small molecules

PAR-21-155 - Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed)

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to correct the Key Dates, Related Announcements, and Application and Submission Information in NOT-CA-21-101, "Notice of Special Interest (NOSI): Advancing the development of tumor site-activated small molecules".

The following subsections of NOT-CA-21-101 have been modified:

Currently Reads:

Key Dates

Release Date: August 16, 2021

First Available Due Date: January 26, 2022

Expiration Date: January 08, 2024

Related Announcements

PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)

PAR-20-292 - NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)

PAR-21-038 - Stephen I. Katz Early-Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)

PAR-19-133 - Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required)

PAR-19-134 - Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)

Application and Submission Information

This Notice applies to due dates on or after January 26, 2022, and subsequent receipt dates through January 08, 2024.

Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcements through the expiration date of this NOSI:

Modified to Read (changes shown in bold italics):

Key Dates

Release Date: August 16, 2021

First Available Due Date: January 8, 2022

Expiration Date: May 8, 2024

Related Announcements

PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)

PAR-20-292 -NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)

PAR-21-038 - Stephen I. Katz Early-Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)

PAR-21-155 - Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed)

PAR-19-134 - Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 - Clinical Trial Not Allowed)

Application and Submission Information

This Notice applies to due dates on or after January 8, 2022, and subsequent receipt dates through May 8, 2024.

Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcements through the expiration date of this NOSI:

All other aspects of NOT-CA-21-101 remain unchanged.

Inquiries

Please direct all inquiries to:

Scientific Research Contact(s)

Sharad K. Verma, PhD
National Cancer Institute (NCI)
Telephone: 202-657-3694
Email: [email protected]

Financial/Grants Management Contact(s)

Crystal Wolfrey
National Cancer Institute (NCI)
Telephone: 240-276-6277
Email: [email protected]